KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNon-Current Deffered RevenueOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPensionPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

West Pharmaceutical Services (WST) Receivables (2016 - 2026)

West Pharmaceutical Services has reported Receivables over the past 18 years, most recently at $701.0 million for Q1 2026.

  • Quarterly Receivables rose 23.11% to $701.0 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $701.0 million through Mar 2026, up 23.11% year-over-year, with the annual reading at $586.3 million for FY2025, 1.82% up from the prior year.
  • Receivables was $701.0 million for Q1 2026 at West Pharmaceutical Services, up from $586.3 million in the prior quarter.
  • Over five years, Receivables peaked at $701.0 million in Q1 2026 and troughed at $502.0 million in Q2 2024.
  • The 5-year median for Receivables is $543.9 million (2024), against an average of $561.9 million.
  • Biggest five-year swings in Receivables: fell 9.68% in 2024 and later grew 23.11% in 2026.
  • Tracing WST's Receivables over 5 years: stood at $523.7 million in 2022, then rose by 1.87% to $533.5 million in 2023, then increased by 7.93% to $575.8 million in 2024, then grew by 1.82% to $586.3 million in 2025, then grew by 19.56% to $701.0 million in 2026.
  • According to Business Quant data, Receivables over the past three periods came in at $701.0 million, $586.3 million, and $652.5 million for Q1 2026, Q4 2025, and Q3 2025 respectively.